.png){kind=icon}
返回
Amyloid-β prediction machine learning model using source-based morphometry across neurocognitive disorders
.png){kind=icon}
OA
AI
DOI：10.1038/s41598-024-58223-3.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Previous studies have developed and explored magnetic resonance imaging (MRI)-based machine learning models for predicting Alzheimer's disease (AD). However, limited research has focused on models incorporating diverse patient populations. This study aimed to build a clinically useful prediction model for amyloid-beta (A beta) deposition using source-based morphometry, using a data-driven algorithm based on independent component analyses. Additionally, we assessed how the predictive accuracies varied with the feature combinations. Data from 118 participants clinically diagnosed with various conditions such as AD, mild cognitive impairment, frontotemporal lobar degeneration, corticobasal syndrome, progressive supranuclear palsy, and psychiatric disorders, as well as healthy controls were used for the development of the model. We used structural MR images, cognitive test results, and apolipoprotein E status for feature selection. Three-dimensional T1-weighted images were preprocessed into voxel-based gray matter images and then subjected to source-based morphometry. We used a support vector machine as a classifier. We applied SHapley Additive exPlanations, a game-theoretical approach, to ensure model accountability. The final model that was based on MR-images, cognitive test results, and apolipoprotein E status yielded 89.8% accuracy and a receiver operating characteristic curve of 0.888. The model based on MR-images alone showed 84.7% accuracy. A beta-positivity was correctly detected in non-AD patients. One of the seven independent components derived from source-based morphometry was considered to represent an AD-related gray matter volume pattern and showed the strongest impact on the model output. A beta-positivity across neurological and psychiatric disorders was predicted with moderate-to-high accuracy and was associated with a probable AD-related gray matter volume pattern. An MRI-based data-driven machine learning approach can be beneficial as a diagnostic aid.
Keyword:
Alzheimer's disease
Amyloid-beta
Machine learning
Magnetic resonance imaging
Source-based morphometry
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3.9
论文数:
27.9W
被引数:
83.5W
机构
引用论文
Incidence and survival of dementia in a general population of Japanese elderly: the Hisayama study
PREAI
分享收藏Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years阿尔茨海默病的病理过程阶段: 1至100岁的年龄类别OAAI
OAAI分享收藏Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven MethodsOAAI
OAAI分享收藏Artificial intelligence in brain MRI analysis of Alzheimer's disease over the past 12 years: A systematic review.png)
AGEING RESEARCH REVIEWS
AGEING RESEARCH REVIEWSIF12.4
PREAI
分享收藏Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 studyALZHEIMERS & DEMENTIAOAAI
ALZHEIMERS & DEMENTIAIF11.1
OAAI分享收藏
查看更多内容